Logo image
Sign in
Impact of the ACCP Antithrombotic Guidelines on Potential Utilization of Dabigatran in Patients With Atrial Fibrillation
Conference proceeding   Peer reviewed

Impact of the ACCP Antithrombotic Guidelines on Potential Utilization of Dabigatran in Patients With Atrial Fibrillation

Mark Malesker, Dayla Boldt, Hua Ling, Tammy Burns and Daniel Hilleman
Chest, Vol.144(4), pp.161-161B
10/2013

Metrics

1 Record Views

Details